CD274 and head and neck squamous cell carcinoma: In this exploratory analysis of patients with R/M HNSCC enrolled in KEYNOTE‐012 and KEYNOTE‐055 who had evaluable WES data, TMB and the inflammatory biomarkers PD‐L1 CPS and TcellinfGEP were independently predictive of ORR to pembrolizumab.